Day, A C
,
Wormald, R
Coronini-Cronberg, S
Smith, R
Article History
First Online: 22 January 2016
Competing interests
: The authors declare the following conflict of interests: The Royal National Institute for Blind People receives money from pharmaceutical companies in the form of educational grants. In recent years, it has been supported by Novartis, Allergan, Alcon and Bayer for initiatives such as the provision of Eye Clinic Liaison Officers in eye clinics. The funding is declared in the RNIB's annual report, and each year the support given by pharmaceutical companies represents <1% of its overall funding. Ms Sophie Coronini-Cronberg is a Consultant in Public Health at BUPA. Alex Day and Richard Wormald were supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology.